Clinical Evidence: What The STEP Trials Actually Show
Understanding Mounjaro And Wegovy Equivalent Doses: Why Direct Comparison Isn't Straightforward
When patients search for Mounjaro and Wegovy equivalent doses, they're often seeking a simple conversion chart between these two prescription weight management treatments. However, direct dose equivalency isn't possible because these medications work through fundamentally different mechanisms. Wegovy (semaglutide) is a selective GLP-1 receptor agonist that mimics a single natural fullness hormone, while Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist affecting two hormone pathways simultaneously.
The clinical approach to determining appropriate dosing for either medication requires individual assessment rather than mathematical conversion between Mounjaro and Wegovy equivalent doses. Both treatments follow their own specific dose escalation schedules designed to minimise side effects whilst optimising therapeutic benefit. Your prescriber will consider your medical history, current medications, weight management goals, and tolerance factors when recommending either Wegovy's five-stage escalation (0.25mg to 2.4mg) or Mounjaro's four-stage progression (2.5mg to 15mg weekly).
Wegovy Pricing Structure: From Starter To Maintenance Doses
Understanding the cost implications of Wegovy's dose escalation helps patients budget for their weight management journey effectively. Our starter dose (0.25mg) costs £79.99 for new customers using code FIRST40, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to the maintenance dose of £209.99 (2.4mg). Returning customers benefit from our DOSE25 discount code applied at checkout, reducing ongoing costs throughout their treatment journey.
Our bundle options provide convenient multi-month supply solutions, such as the Intro Trio (0.25mg, 0.5mg, 1mg) for £299.99, covering your first 12 weeks of treatment. The Ultimate Stability Trio offers three 2.4mg maintenance pens for £649.99, ensuring consistent supply once you've reached your optimal dose. These bundles eliminate the need for multiple orders and assurance cold-chain integrity through single delivery, though individual pen pricing offers maximum flexibility for dose adjustments.
STEP Trial Evidence: What Clinical Research Shows About Wegovy Results
The landmark STEP clinical trial programme provides robust evidence for Wegovy's weight management efficacy when used alongside reduced-calorie diet and increased physical activity. In the pivotal STEP 1 trial, patients taking Wegovy achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). STEP 3 demonstrated that intensive behavioural therapy combined with Wegovy supported approximately 16% average weight reduction.
Long-term sustainability was evaluated in STEP 5, where participants maintained approximately clinically studied weight loss at two years of continuous treatment. The SELECT cardiovascular outcomes trial showed a 20% reduction in major adverse cardiovascular events, highlighting potential benefits beyond weight management. These results represent averages from controlled clinical trials and individual outcomes may vary based on adherence to lifestyle modifications and personal medical factors.
How Wegovy Works: GLP-1 Receptor Mechanism Explained
Wegovy functions as a GLP-1 receptor agonist, mimicking the action of glucagon-like peptide-1, a hormone naturally produced in your intestines after eating. This mechanism promotes feelings of fullness and satiety by slowing gastric emptying, meaning food remains in your stomach longer, contributing to reduced appetite between meals. The medication also acts on appetite control centres in the brain, potentially reducing food cravings and the psychological drive to eat. Unlike surgical interventions, Wegovy's effects are reversible and dose-dependent, allowing for personalised treatment approaches. When combined with reduced-calorie diet and increased physical activity, this multi-pathway approach supports sustainable weight management habits. The once-weekly injection schedule helps maintain consistent therapeutic levels whilst minimising the burden of daily medication routines.
EverydayMeds Ordering Process: Assessment To Delivery
Our streamlined ordering process begins with a comprehensive 3-minute online clinical assessment covering your medical history, current medications, weight management goals, and lifestyle factors relevant to Wegovy prescription. Following submission, our clinical team conducts a thorough prescriber review, typically completed within 3 working days, with express 24-hour review available for urgent requirements. Once approved, your Wegovy prescription is dispensed by our GPhC-registered pharmacy (#9012878) and prepared for cold-chain delivery. Our temperature-controlled courier service ensures your medication maintains optimal storage conditions from our pharmacy to your door via next-day delivery. The entire process maintains strict confidentiality whilst ensuring clinical safety and regulatory compliance throughout your weight management journey.
Storage And Practical Considerations: Wegovy Versus Mounjaro
Wegovy offers superior storage flexibility compared to Mounjaro, particularly important for UK patients who travel frequently or have variable schedules. Once removed from refrigeration, Wegovy remains stable for up to 6 weeks at room temperature below 30°C, compared to Mounjaro's 21-day room temperature limit. Both medications require refrigeration at 2-8°C before first use, but Wegovy's extended room temperature stability provides greater practical convenience. The FlexTouch pen design is pre-filled and ready to use, with clear dosing windows and audible click confirmation for accurate injection. Dose escalation cannot be skipped with either medication, as the gradual increase minimises gastrointestinal side effects whilst allowing your body to adjust to increasing therapeutic levels. Both treatments are administered once weekly, making them suitable for busy lifestyles compared to daily medication regimens.
UK Clinical Evidence: Why Mounjaro And Wegovy Equivalent Doses Matter For Patient Choice
The question of Mounjaro and Wegovy equivalent doses reflects patients' desire to understand their treatment options within the UK's regulated weight management landscape. NICE guidance (TA875) recommends Wegovy for eligible patients with specialist support, whilst Mounjaro recently received MHRA approval with its own specific indications and dosing protocols. Both medications represent significant advances in pharmacological weight management, offering alternatives to surgical interventions for appropriate candidates.
Rather than seeking direct equivalency between Mounjaro and Wegovy equivalent doses, patients benefit from understanding how each medication's unique mechanism aligns with their individual circumstances. Your prescriber will evaluate factors including previous weight management attempts, comorbidities, medication tolerance, and lifestyle considerations when recommending treatment options. This personalised approach ensures optimal therapeutic outcomes whilst minimising potential adverse effects through appropriate dose selection and monitoring protocols.
Complete Your Wegovy Assessment Today: Next-Day Delivery Available
Both Wegovy and Mounjaro are available from EverydayMeds through our comprehensive online prescribing service, though direct dose equivalency isn't clinically appropriate given their different mechanisms of action. New customers can access Wegovy from £79.99 using discount code FIRST40, whilst returning patients benefit from DOSE25 pricing throughout their treatment journey. Our clinical team provides ongoing support throughout dose escalation, ensuring optimal therapeutic outcomes whilst monitoring for any adjustment needs. The convenience of next-day cold-chain delivery eliminates supply interruptions that could compromise your weight management progress. Complete your clinical assessment today to begin your evidence-based weight management journey with full prescriber support and pharmaceutical-grade medication quality. As a prescription-only medicine, Wegovy requires clinical assessment and ongoing monitoring to ensure safe, effective treatment outcomes tailored to your individual health profile.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
